Apart from the fact that TG2 inhibition suppresses the RCC tumor growth by p53-mediated apoptosis, little detail is known about the role of TG2 in modulating p53 activity in the context of lung cancer. This evidence concerns the gene TGM2 and renal cell carcinoma.